Immunyx Pharma USA Inc.

New York, NY

UEI
SLHND6A732S3
CAGE
9EBU0
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
210 W 90th St, New York, NY 10024, USA
Website
immunyx.com
Founded
2021
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Immunyx Pharma USA Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of imyx-3 for the treatment of ulcerative colitis - abstract ulcerative colitis (UC) is a chronic,… Grant · R44DK145292 National Institute of Diabetes and Digestive and Kidney Diseases $4,056,301

Quick answers

What is Immunyx Pharma USA Inc.'s UEI?

Immunyx Pharma USA Inc.'s Unique Entity ID (UEI) in SAM.gov is SLHND6A732S3.

What is Immunyx Pharma USA Inc.'s CAGE code?

Immunyx Pharma USA Inc.'s CAGE code is 9EBU0.

What is Immunyx Pharma USA Inc.'s primary NAICS code?

Immunyx Pharma USA Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Immunyx Pharma USA Inc. located?

Immunyx Pharma USA Inc.'s physical address in SAM.gov is 210 W 90th St, New York, NY 10024, USA.

Is Immunyx Pharma USA Inc. registered in SAM.gov?

Yes. Immunyx Pharma USA Inc.'s SAM.gov registration is active through June 29, 2027.

What is Immunyx Pharma USA Inc.'s most recent federal award?

Immunyx Pharma USA Inc.'s most recent federal grant award is Development of imyx-3 for the treatment of ulcerative colitis - abstract ulcerative colitis (UC) is a chronic,… (R44DK145292), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 15, 2025.

On GovTribe

See Immunyx Pharma USA Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors